Skip to main content

Alumni updates are submitted by your fellow alumni. Read what they are up to below or submit your own update.

Submit an Alumni Update

  • Katherine Worsley-Tonks, ’20, PhD, has accepted a post-doctoral fellowship at the Smithsonian Institute. Worsley-Tonks was advised by Dominic Travis, DVM, MS.

  • Andrew Brothers, ‘20 DVM, started a new position as Associate Veterinarian at Blue River PetCare in the Twin Cities.

    Issue: Fall 2020
  • Christina Larson, '20 DVM, PhD,  accepted a tenure-track assistant professor position at SDSU in their Veterinary and Biomedical Sciences department.

  • Katie Cornille, ’20 DVM, started a new position as supervisory public health veterinarian as USDA-FSIS in St. Cloud, Minn., in June 2020. 


  • Mikayla Dolan, ‘20 DVM, started a new position as a rotating intern with Animal Emergency and Referral Center of MN. Previously she worked as a Veterinary Assistant at Banfield Pet Hospital and Pet Dermatology clinic in Maple Grove, Minnesota. After graduation from the U of M she became an Animal Care Technician at the Mayo Clinic in Rochester, Minnesota.

    Issue: Fall 2020
  • Anna Munsey, DVM, ’20 PhD, advised by Andres Perez, DVM, PhD, has accepted a Centers for Disease Control Teutsch Prevention Effectiveness Fellowship. The two-year fellowship is with the Center for Global Health, Division of Parasitic Diseases and Malaria. Munsey will start the fellowship in August.

  • Amanda Salzwedel, ’11 DVM, MS, PhD, started a new position in January as a senior research biologist at 3M within the company’s Biomaterials Technology Group. Salzwedel was advised by Srinand Sreevatsan, BVSc, MVSc, MPH, PhD.

  • Xiong (Sean) Wang ’16 DVM, published a manuscript quoted in a paper written by Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, and Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.

  • Jyotika Varshney ’16 PhD, founded a research development company, VeriSim Life, that was recently recognized for novel pharmaceutical development approaches. Varshney was advised by Subree Subramanian, PhD.